Quick answers
- What is Isovue 200?
- Isovue 200 is a brand name of Iopamidol, a prescription medicine. The FDA NDC Directory lists 1 Isovue 200 product in 1 strength and form.
- Who makes Isovue 200?
- Bracco holds the FDA application for Isovue 200 (NDA018735, approved December 31, 1985).
- Is there a generic or store brand of Isovue 200?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Isovue 200 product, 2 of them generic. Ask your pharmacist whether one is right for you.
- Has Isovue 200 been recalled?
- No recall linked to Isovue 200 products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Isovue 200 is
Each Isovue 200 product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Iopamidol · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| iopamidol 408 mg/mL injection, solution (intravascular) | Isovue 200 | 3 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Iopamidol →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA018735 | Bracco | December 31, 1985 | 1 |
Companies that list Isovue 200
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Isovue 200 products.
- Bracco Diagnostics Inc1 product
Recalls
No recall linked to Isovue 200 products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.